Reviewer's report
Title:Access to Primary Care is Associated with Better Autoimmune Hepatitis
Outcomes in an Urban County Hospital
Version:2Date:5 March 2015
Reviewer: Robert Gish
Reviewer's report:
Major Compulsory Revisions
1) The abstract needs to be updated with improved English and Syntax
2) The authors need to outline the access to GI/Liver specialists
3) What systems are proposed to decrease loss to follow up patients?
4) Who performed the the dose of the immune suppressant medications?
5) Was there a call back system for patients on medications?
6) Did the authors use a national database such as MediCare or other system to
track death rate outside the county health care system to search for those "lost to
follow up"?
7) Was the MELD score applied to all patients or only those with cirrhosis?
Minor Essential Revisions
PBC name has been changed to primary biliary cholangitis, reference J Hep,
WHO website ICD-11, PBCers, PBC Foundation websites
AST and ALT are not liver function tests: these are liver enzymes
Bili, Alb and INR are liver function tests using 2015 terminology
IV prednisolone is very rarely used for AIH: who received IV steroids, why and for
how long ?
Discretionary Revisions
the graphs appear blurry when reviewed, high quality TIFF files would be
supported
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Have you in the past five years received reimbursements, fees, funding, or salary
from an organisation that may in any way gain or lose financially from the
publication of this paper, either now or in the future?
no
Do you hold any stocks or shares in an organisation that may in any way gain or
lose financially from the publication of this paper, either now or in the future?
no
Do you hold or are you currently applying for any patents relating to the content
of the manuscript?
No
Have you received reimbursements, fees, funding, or salary from an organization
that holds or has applied for patents relating to the content of the manuscript?
no
Do you have any other financial competing interests?
no
Do you have any non-financial competing interests in relation to this paper?
no
'I declare that I have no competing interests'
RGG
Reviewer's report
Title:Access to Primary Care is Associated with Better Autoimmune Hepatitis
Outcomes in an Urban County Hospital
Version:2Date:5 March 2015
Reviewer: Robert Gish
Reviewer's report:
Major Compulsory Revisions
1) The abstract needs to be updated with improved English and Syntax
2) The authors need to outline the access to GI/Liver specialists
3) What systems are proposed to decrease loss to follow up patients?
4) Who performed the the dose of the immune suppressant medications?
5) Was there a call back system for patients on medications?
6) Did the authors use a national database such as MediCare or other system to
track death rate outside the county health care system to search for those "lost to
follow up"?
7) Was the MELD score applied to all patients or only those with cirrhosis?
Minor Essential Revisions
PBC name has been changed to primary biliary cholangitis, reference J Hep,
WHO website ICD-11, PBCers, PBC Foundation websites
AST and ALT are not liver function tests: these are liver enzymes
Bili, Alb and INR are liver function tests using 2015 terminology
IV prednisolone is very rarely used for AIH: who received IV steroids, why and for
how long ?
Discretionary Revisions
the graphs appear blurry when reviewed, high quality TIFF files would be
supported
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Have you in the past five years received reimbursements, fees, funding, or salary
from an organisation that may in any way gain or lose financially from the
publication of this paper, either now or in the future?
no
Do you hold any stocks or shares in an organisation that may in any way gain or
lose financially from the publication of this paper, either now or in the future?
no
Do you hold or are you currently applying for any patents relating to the content
of the manuscript?
No
Have you received reimbursements, fees, funding, or salary from an organization
that holds or has applied for patents relating to the content of the manuscript?
no
Do you have any other financial competing interests?
no
Do you have any non-financial competing interests in relation to this paper?
no
'I declare that I have no competing interests'
RGG
Please review this paper.
user
Reviewer's report
Title:Access to Primary Care is Associated with Better Autoimmune Hepatitis
Outcomes in an Urban County Hospital
Version:2Date:5 March 2015
Reviewer: Robert Gish
Reviewer's report:
Major Compulsory Revisions
1) The abstract needs to be updated with improved English and Syntax
2) The authors need to outline the access to GI/Liver specialists
3) What systems are proposed to decrease loss to follow up patients?
4) Who performed the the dose of the immune suppressant medications?
5) Was there a call back system for patients on medications?
6) Did the authors use a national database such as MediCare or other system to
track death rate outside the county health care system to search for those "lost to
follow up"?
7) Was the MELD score applied to all patients or only those with cirrhosis?
Minor Essential Revisions
PBC name has been changed to primary biliary cholangitis, reference J Hep,
WHO website ICD-11, PBCers, PBC Foundation websites
AST and ALT are not liver function tests: these are liver enzymes
Bili, Alb and INR are liver function tests using 2015 terminology
IV prednisolone is very rarely used for AIH: who received IV steroids, why and for
how long ?
Discretionary Revisions
the graphs appear blurry when reviewed, high quality TIFF files would be
supported
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
Have you in the past five years received reimbursements, fees, funding, or salary
from an organisation that may in any way gain or lose financially from the
publication of this paper, either now or in the future?
no
Do you hold any stocks or shares in an organisation that may in any way gain or
lose financially from the publication of this paper, either now or in the future?
no
Do you hold or are you currently applying for any patents relating to the content
of the manuscript?
No
Have you received reimbursements, fees, funding, or salary from an organization
that holds or has applied for patents relating to the content of the manuscript?
no
Do you have any other financial competing interests?
no
Do you have any non-financial competing interests in relation to this paper?
no
'I declare that I have no competing interests'
RGG
assistant